Si-Bone is a medical devices business based in the US. Si-Bone shares (SIBN) are listed on the NASDAQ and all prices are listed in US Dollars. Si-Bone employs 344 staff and has a trailing 12-month revenue of around $150.7 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $15.08 |
|---|---|
| 52-week range | $11.76 - $23.25 |
| 50-day moving average | $15.03 |
| 200-day moving average | $16.55 |
| Wall St. target price | $23.56 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-1.00 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $15.08 from 2024-09-11
| 1 week (2024-09-05) | -4.74% |
|---|---|
| 1 month (2024-08-12) | 7.03% |
| 3 months (2024-06-12) | 13.04% |
| 6 months (2024-03-12) | -12.83% |
| 1 year (2023-09-12) | -32.47% |
|---|---|
| 2 years (2022-09-12) | -16.50% |
| 3 years (2021-09-10) | 22.7 |
| 5 years (2019-09-12) | 19.55 |
| Revenue TTM | $150.7 million |
|---|---|
| Gross profit TTM | $90.7 million |
| Return on assets TTM | -12.51% |
| Return on equity TTM | -23.88% |
| Profit margin | -27.1% |
| Book value | $3.97 |
| Market Capitalization | $626.7 million |
TTM: trailing 12 months
We're not expecting Si-Bone to pay a dividend over the next 12 months.
Over the last 12 months, Si-Bone's shares have ranged in value from as little as $11.76 up to $23.25. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Si-Bone's is 1.232. This would suggest that Si-Bone's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
SI-BONE, Inc. , a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
These are the best day trading platforms, according to Finder’s comprehensive analysis.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out the best-performing ETFs so far in 2024.